tm
Seeing Is Believing
tm
Seeing Is Believing
Aeglea Bio Therapeutics's activity chart (see below) currently has 31 price targets and 31 ratings on display.
Analysts average stock forecasts to be materialized ratio is 45.24% with an average time for these price targets to be met of 68.93 days.
Most recent stock forecast was given by from WELLS FARGO on 13-Nov-2023. First documented stock forecast 09-May-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Aug-2023
$12
$-15.6 (-56.52%)
$12.5
2 years 10 months 25 days ago
(13-Nov-2023)
2/2 (100%)
$1.82 (17.88%)
10
Buy Since 25-Jul-2023
$23
$-4.6 (-16.67%)
$22.5
2 years 11 months 15 days ago
(23-Oct-2023)
2/2 (100%)
$10.59 (85.33%)
120
Hold Since 03-Mar-2023
3 years 7 months 5 days ago
(03-Mar-2023)
0/3 (0%)
$161.25 (75.44%)
Buy Since 27-Oct-2022
$25
3 years 11 months 11 days ago
(27-Oct-2022)
1/4 (25%)
$6.75 (36.99%)
151
Buy Since 04-Feb-2022
4 years 4 months 5 days ago
(03-Jun-2022)
3/3 (100%)
$-30.5 (-77.22%)
161
What is AGLE (Aeglea Bio Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on AGLE (Aeglea Bio Therapeutics)?
Which analyst has the most public recommendations on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most bullish on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most reserved on AGLE (Aeglea Bio Therapeutics)?
